Medtronic is capturing demand for its cutting-edge solutions, as recent product launches emerge to drive new growth. With the ...
Medtronic is a solid dividend-paying stock. Its stock recently yielded 3.2%. It has increased its payout for nearly 50 years in a row. If you're a dividend investor, I can understand why ...
In the most recent trading session, Medtronic (MDT) closed at $91.99, indicating a +0.63% shift from the previous trading day.
The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.
chief medical officer at Medtronic's cardiovascular diagnostics and services division. AstraZeneca has announced another major investment in Canada, tapping into the country's emergence as a ...